Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group.

H Gogas; C Papadimitriou; H P Kalofonos; D Bafaloukos; G Fountzilas; D Tsavdaridis; A Anagnostopoulos; A Onyenadum; P Papakostas; T Economopoulos

doi:10.1093/annonc/mdf284

Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group.

Identifier:nobleid.org/w1/20260515/BBC01CDA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BBC01CDA.svg?ark=w1%2F20260515%2FBBC01CDA)](https://nobleid.org/work/w1/20260515/BBC01CDA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Neoadjuvant chemotherapy with a combination of pegylated liposomal doxorubicin (Caelyx) and paclitaxel in locally advanced breast cancer: a phase II study by the Hellenic Cooperative Oncology Group.

Identifier:nobleid.org/w1/20260515/BBC01CDA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BBC01CDA.svg?ark=w1%2F20260515%2FBBC01CDA)](https://nobleid.org/work/w1/20260515/BBC01CDA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work